TABLE 1

Effective Dose for Whole Body in Sv/GBq and Absorbed Doses for Normal Organs in Gy/GBq

Cycles investigatedWhole bodyKidneys*LiverParotid glands*Submandibular glands*Lacrimal glands*
Overall (n = 34)
 Mean ± SD0.06 ± 0.03†0.72 ± 0.210.12 ± 0.060.55 ± 0.140.64 ± 0.403.8 ± 1.4
 Range0.02–0.110.33–1.220.05–0.260.25–0.840.24–1.701.68–7.03
First cycle (n = 15)
 Mean ± SD0.05 ± 0.030.71 ± 0.250.12 ± 0.070.56 ± 0.170.54 ± 0.293.8 ± 1.5
 Range0.02–0.110.33–1.220.05–0.260.25–0.840.25–1.351.68–7.03
Second cycle (n = 9)
 Mean ± SD0.06 ± 0.020.75 ± 0.190.13 ± 0.050.59 ± 0.130.71 ± 0.424.1 ± 1.1
 Range0.03–0.110.44–1.010.08–0.210.47–0.800.40–1.702.44–5.56
Third cycle (n = 5)
 Mean ± SD0.06 ± 0.030.73 ± 0.220.12 ± 0.060.49 ± 0.110.83 ± 0.593.5 ± 1.4
 Range0.03–0.100.42–0.930.07–0.210.32–0.640.33–1.682.41–5.04
Fourth cycle (n = 5)
 Mean ± SD0.05 ± 0.030.69 ± 0.180.11 ± 0.040.50 ± 0.110.66 ± 0.533.4 ± 1.7
 Range0.03–0.110.45–0.950.07–0.170.32–0.580.24–1.581.75–5.35

  • ↵* Absorbed doses for paired organs are presented as average between right and left side.

  • ↵† Median value: 0.03 Sv/GBq (for comparison with Baum et al.).